Policy Notices

• The Agency for Healthcare Research and Quality Data Management Plan Policy
  (NOT-HS-20-011)
  Agency for Healthcare Research and Quality
  

General Notices

• NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-19-328: Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
  (NOT-HL-20-791)
  National Heart, Lung, and Blood Institute
  

• Request for Information (RFI): Input on data sources and data science questions to advance research on alcohol use
  (NOT-AA-20-013)
  National Institute on Alcohol Abuse and Alcoholism
  

• Request for Information (RFI): Input to Enhance the Impact of the NCI Experimental Therapeutics Programs Chemical Biology Consortium on Cancer Drug Discovery and Development
  (NOT-CA-20-071)
  National Cancer Institute
  

• Request for Information (RFI): Advancing Scientific and Workforce Diversity in the BRAIN Initiative
  (NOT-MH-20-051)
  National Institute of Mental Health
  

Notice of Changes to Funding Opportunities

• Notice of NCI's Participation in PA-20-201, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
  (NOT-CA-20-070)
  National Cancer Institute
  

• Notice of Early Expiration of Notice of Special Interest (NOSI): Administrative Supplements to Existing R01 Grants on Polycystic Kidney Disease (PKD)
  (NOT-DK-20-032)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Change in Application Due Date for RFA-HL-19-015 "Physician-Scientist (PS) Research Awardfor Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)"
  (NOT-HL-20-793)
  National Heart, Lung, and Blood Institute
  

• Notice to Extend RFA-MH-20-510, "Laboratories to Optimize Digital Health (R01 Clinical Trial Required)"
  (NOT-MH-20-054)
  National Institute of Mental Health
  

• Notice of Change to Budget for PAR-18-833, Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
  (NOT-MH-20-056)
  National Institute of Mental Health
  

• Notice of Change to Budget for PAR-18-832 AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
  (NOT-MH-20-057)
  National Institute of Mental Health
  

• Notice of Change to Eligible Activity Codes for NOT-NS-20-051 "Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System"
  (NOT-NS-20-074)
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)
  (NOT-AT-20-012)
  National Center for Complementary and Integrative Health
  

• Notice of Special Interest (NOSI): Administrative Supplements to Existing R01 Grants on Polycystic Kidney Disease (PKD)
  (NOT-DK-20-033)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Special Interest: Promoting Fundamental and Applied Research in Inflammation Resolution
  (NOT-ES-20-018)
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) related Research
  (NOT-OD-20-107)
  National Institutes of Health
  

Funding Opportunities

• Limited Competition: National Primate Research Centers (P51) Program
  (PAR-20-181)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply. The first standard application due date for this FOA is September 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C/TL1 - Clinical Trial Not Allowed)
  (PAR-20-220)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): September 28, 2020, September 28, 2021, September 28, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Development of Cost-Effective and Customizable Training and Education Platforms for AD/ADRD Caregivers that Focus on Addressing Financial Management and Legal Planning (R43/R44 Clinical Trial Not Allowed)
  (RFA-AG-21-025)
  National Institute on Aging
  Application Receipt Date(s): November 12, 2020
  
  

• Collaborative Pediatric Critical Care Research Network (PL1 Clinical Trial Required)
  (RFA-HD-21-016)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.